VINC Insider Trading
Insider Ownership Percentage: 15.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Vincerx Pharma Insider Trading History Chart
This chart shows the insider buying and selling history at Vincerx Pharma by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Vincerx Pharma Share Price & Price History
Current Price: $0.66
Price Change: ▲ Price Increase of +0.0298 (4.73%)
As of 04/3/2025 05:00 PM ET
Vincerx Pharma Insider Trading History
Vincerx Pharma Institutional Trading History
Data available starting January 2016
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.
Read More on Vincerx Pharma
Volume
424,375 shs
Average Volume
344,190 shs
Market Capitalization
$1.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.43
Who are the company insiders with the largest holdings of Vincerx Pharma?